GET THE APP

REM Sleep Behavior Disorder (RBD)-A Potential Predictive Biomarkers of Future Neurodegeneration
Journal of Sleep Disorders & Therapy

Journal of Sleep Disorders & Therapy
Open Access

ISSN: 2167-0277

+44 20 3868 9735

Editorial - (2012) Volume 1, Issue 2

REM Sleep Behavior Disorder (RBD)-A Potential Predictive Biomarkers of Future Neurodegeneration

Zhang Xi*
Sleep Medicine Research Center, Chinese PLA General Hospital, P.R. China
*Corresponding Author: Zhang Xi, Professor, Sleep Medicine Research Center, Department of Geriatric Neurology, Institute of Geriatrics & Gerontology, Chinese PLA General Hospital, P.R. China Email:

REM sleep behavior disorder (RBD) is a novel type of Parasomnias characterized by abnormal behavioral manifestations during REM sleep [1]. RBD affects 0.4-0.5% of the elderly population with a typical age of onset in 50s-60s [2-5]. RBD presents with a spectrum of dreamenacting behavioral manifestations, including sleep shouting, fisting, kicking or falling out of bed with a high prevalence of sleep-related injuries to themselves or/and bed-partners [2-5].

Accumulating evidences suggests that idiopathic RBD (iRBD) is an integrated part of disease progress in α-synucleinopathy neurodegeneration, such as Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) [2-9]. Longitudinal clinical studies suggests that the estimated 5-year risk of developing any neurodegenerative disorder in iRBD patients range from 8.5%-38%, which increase to 38%-65% at around 10- year follow-up [5-9]. Hence, the time gap between RBD and neurodegenerative disorders may potentially provide a therapeutic window for neuroprotective measures in halting the underlying neurodegeneration at an early stage. Thus, research also focused on the identification of subclinical markers of neurodegeneration in iRBD, including color vision deficit and olfactory dysfunction [10-11], which might be construed as the early stages of neurodegenerative process [12]. Additionally, polysomnographic feature of RBD has also been reported as a predictive marker of neurodegeneration [13,14]. Nonetheless, studies were limited by cross-sectional design with relatively small sample size.

Early neurodegeneration in RBD could be demonstrated by brain imaging technologies. Studies suggested that iRBD was associated with dopaminergic neurotransmission abnormalities [15-17], with a progressive decline of the striatal presynaptic dopaminergic transporter from subclinical RBD, iRBD to RBD with PD [15-17]. Up to date, only two studies reported the longitudinal course of dopamine abnormalities in iRBD. Miyamoto et al. [18] found that the dopamine uptake decreased by 4-6% per year. Another prospective case-control study of 20 Spanish iRBD of 3 years reported a significant decline in dopamine uptake in iRBD group, and those developed Parkinson’s disease had the lowest dopamine uptake at baseline [19]. Although brain imaging techniques show a high sensitivity in detecting neurodegeneration, they are expensive with limited accessibility for routine screening of early neurodegeneration among RBD patients. Thus, the search of reliable and easily applicable clinical markers is important. Eisensehr et al. [17] correlated the increase in muscle activity during REM sleep to reduction of striatal dopamine transporters. Another study found that there were correlations between cerebral blood flow and color vision and olfactory abnormalities [20]. These studies have provided preliminary results of the possible correlations between clinical markers and neuroimaging findings.

Over past decade, the epidemiological study of RBD in Hong Kong Chinese was conducted by Hong Kong sleep centre [4,9,20-25]. They reported the largest cohort of Chinese RBD patients (n=82) [4]. Recently, prospective follow-up study on this cohort of iRBD patients [n=81, mean follow-up duration=5.6 years (s.d.3.3),] reported that the estimated 5-year and 9-year risk of developing any neurodegenerative disorder was 8.5% and 38.1%, respectively [9], which were comparable to the Caucasian figures [8]. In addition, presence of pre-morbid psychiatric disorder was associated with an increased risk of development of PD [24,26]. Wing and his colleagues found that a single night of vPSG in the presence of suggestive clinical history was adequate in establishing RBD diagnosis among 80-95% of the patients [22]. As there have been limited screening instruments for diagnosis and monitoring of RBD, they developed and validated a novel RBD instrument (RBDQ-HK) with satisfactory validity and reliability [23].

The further research work should be conducted to determine the early clinical and neurobiological markers in predicting an increased risk of neurodegeneration in idiopathic RBD patients, and to prospectively correlate the potential clinical markers with brain imaging abnormalities.

Acknowledgements

I would like to thank Dr. YK Wing for the assistance in the article editing.

References

  1. Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW (1986) Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 9: 293-308.
  2. Schenck CH, Mahowald MW (2002) REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 25: 120-138.
  3. Olson EJ, Boeve BF, Silber MH (2000) Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 123: 331-339.
  4. Wing YK, Lam SP, Li SX, Yu MW, Fong SY, et al. (2008) REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison. J Neurol Neurosurg Psychiatry 79: 1415-1416.
  5. Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Marti MJ, et al. (2006) Rapid-eye movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5: 572-577.
  6. Schenck CH, Bundlie SR, Mahowald MW (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46: 388-393.
  7. Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE (2001) Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 16: 622-630.
  8. Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, et al. (2009) Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 72: 1296-1300.
  9. Wing YK, Li SX, Mok V, Lam SP, Tsoh J, et al. (2012) Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson’s disease. J Neurol Neurosurg Psychiatry.
  10. Ferini-Strambi L, Di Gioia MR, Castronovo V, Oldani A, Zucconi M, et al. (2004) Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist? Neurology 62: 41-45.
  11. Postuma RB, Gagnon JF, Vendette M, Montplaisir JY (2009) Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson’s disease. Brain 132: 3298-3307.
  12. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, et al. (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130: 2770-2788.
  13. Postuma RB, Gagnon JF, Rompre S, Montplaisir JY (2010) Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease. Neurology 74: 239-244.
  14. Iranzo A, Ratti PL, Casanova-Molla J, Serradell M, Vilaseca I, et al. (2009) Excessive muscle activity increases over time in idiopathic REM sleep behavior disorder. Sleep 32: 1149-1153.
  15. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, et al. (2000) Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with parkinson’s disease and controls. Brain 123: 1155-1160.
  16. Albin RL, Koeppe RA, Chervin RD, Consens FB, Wernette K, et al. (2000) Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 55: 1410-1412.
  17. Eisensehr I, Linke R, Tatsch K, Kharraz B, Gildehaus JF, et al. (2003) Increased muscle activity during rapid eye movement sleep correlates with decreased of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, parkinson’s disease, and controls. Sleep 26: 507-512.
  18. Miyamoto T, Orimo S, Miyamoto M, Hirata K, Adachi T, et al. (2010) Follow-up PET studies in case of idiopathic REM sleep behavior disorder. Sleep Med 11: 100-101.
  19. Iranzo A, Valldeoriola F, Lomeña F, Molinuevo JL, Serradell M, et al. (2011) Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 10: 797-805.
  20. Chiu HF, Wing YK, Lam LC, Li SW, Lum CM, et al. (2000) Sleep-related injury in the elderly – an epidemiological study in Hong Kong. Sleep 23: 513-517.
  21. Lam SP, Fong SY, Ho CK, Yu MW, Wing YK (2008) Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional study. J Clin Psychiatry 69: 1374-1382.
  22. Zhang J, Lam SP, Ho CK, Li AM, Tsoh J, et al. (2008) Diagnosis of REM sleep behavior disorder by video-polysomnographic study: is one night enough? Sleep 31: 1179-1185.
  23. Li SX, Wing YK, Lam SP, Zhang J, Yu MW, et al. (2010) Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK). Sleep Med 11: 43-48.
  24. Lam SP, Zhang J, Tsoh J, Li SX, Ho CK, et al. (2010) REM sleep behavior disorder in psychiatric populations. J Clin Psychiatry 71: 1101-1103.
  25. Wing YK, Li RH, Lam CW, Ho CK, Fong SY, et al. (2002) The prevalence of narcolepsy among Chinese in Hong Kong. Ann Neurol 51: 578-584.
  26. Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervations in the limbic system. Brain 128: 1314-1322.
  27. Vendette M, Gagnon JF, Soucy JP, Gosselin N, Postuma RB, et al. (2011) Brain perfusion and markers of neurodegeneration in rapid eye movement sleep behavior disorder. Mov Disord 26: 1717-1724.
Citation: Xi Z (2012) REM Sleep Behavior Disorder (RBD)-A Potential Predictive Biomarkers of Future Neurodegeneration. J Sleep Disord Ther 1:e107.

Copyright: © 2012 Xi Z. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.